Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease

Geert R. D'Haens, Richard Fedorak, Marc Lémann, Brian G. Feagan, Michael A. Kamm, Jacques Cosnes, Paul J. Rutgeerts, Philippe Marteau, Simon Travis, Jürgen Schölmerich, Steven Hanauer, William J. Sandborn

Research output: Contribution to journalReview articlepeer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology